SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 66 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,000 | -14.3% | 902 | +38.8% | 0.00% | – |
| Q3 2019 | $7,000 | +16.7% | 650 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | 0.0% | 650 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 650 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | -71.4% | 650 | -43.5% | 0.00% | – |
| Q3 2018 | $14,000 | 0.0% | 1,150 | 0.0% | 0.00% | – |
| Q2 2018 | $14,000 | 0.0% | 1,150 | 0.0% | 0.00% | – |
| Q1 2018 | $14,000 | +100.0% | 1,150 | +130.0% | 0.00% | – |
| Q3 2017 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |